Impaired Hypoglycemic Awareness clinical trials at UCSF

1 research study open to eligible people

VX-880 in Participants With Type 1 Diabetes
open to eligible people ages 18-65
This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.
San Francisco, California and other locations

Last updated: March 3, 2025